NCT02759276View on ClinicalTrials.gov

Microcirculation and Inflammatory Markers in Patients With Resistant, Stages 1/2 Hypertension and Normal Blood Pressure

CompletedOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
High Blood Pressure
All Listed Sponsors
collaborator

Rio de Janeiro State University

OTHER

lead

Daniel Alexandre Bottino

OTHER

NCT02759276 - Microcirculation and Inflammatory Markers in Patients With Resistant, Stages 1/2 Hypertension and Normal Blood Pressure | Biotech Hunter | Biotech Hunter